10.22
price down icon0.87%   -0.09
after-market Dopo l'orario di chiusura: 10.22
loading
Precedente Chiudi:
$10.31
Aprire:
$10.17
Volume 24 ore:
1.04M
Relative Volume:
0.48
Capitalizzazione di mercato:
$879.40M
Reddito:
$139.71M
Utile/perdita netta:
$-209.36M
Rapporto P/E:
-3.4527
EPS:
-2.96
Flusso di cassa netto:
$-160.60M
1 W Prestazione:
+10.49%
1M Prestazione:
+11.21%
6M Prestazione:
-29.08%
1 anno Prestazione:
-56.10%
Intervallo 1D:
Value
$10.17
$10.50
Intervallo di 1 settimana:
Value
$9.16
$10.50
Portata 52W:
Value
$8.58
$25.07

Syndax Pharmaceuticals Inc Stock (SNDX) Company Profile

Name
Nome
Syndax Pharmaceuticals Inc
Name
Telefono
781-419-1400
Name
Indirizzo
730 THIRD AVENUE, NEW YORK, MA
Name
Dipendente
184
Name
Cinguettio
@syndax
Name
Prossima data di guadagno
2025-03-03
Name
Ultimi documenti SEC
Name
SNDX's Discussions on Twitter

Confronta SNDX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SNDX
Syndax Pharmaceuticals Inc
10.22 887.15M 139.71M -209.36M -160.60M -2.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Syndax Pharmaceuticals Inc Stock (SNDX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-10 Iniziato Goldman Buy
2024-10-24 Iniziato UBS Buy
2024-06-28 Iniziato Jefferies Buy
2024-01-31 Downgrade Scotiabank Sector Outperform → Sector Perform
2023-12-22 Iniziato Mizuho Buy
2023-10-25 Iniziato BofA Securities Buy
2023-10-11 Iniziato Goldman Buy
2023-07-27 Iniziato Scotiabank Sector Outperform
2023-07-11 Iniziato Guggenheim Buy
2023-04-17 Ripresa BTIG Research Buy
2023-01-31 Iniziato Stifel Buy
2023-01-03 Iniziato JP Morgan Overweight
2022-07-28 Ripresa B. Riley Securities Buy
2022-04-11 Iniziato H.C. Wainwright Buy
2022-02-15 Iniziato Goldman Buy
2021-06-04 Ripresa Robert W. Baird Outperform
2021-05-25 Iniziato Citigroup Buy
2021-02-18 Iniziato B. Riley Securities Buy
2020-12-03 Iniziato Stifel Buy
2020-05-22 Aggiornamento Citigroup Neutral → Buy
2020-05-22 Downgrade H.C. Wainwright Buy → Neutral
2020-05-18 Downgrade Citigroup Buy → Neutral
2020-05-11 Reiterato H.C. Wainwright Buy
2020-03-04 Iniziato Barclays Overweight
2020-01-13 Reiterato H.C. Wainwright Buy
2019-03-08 Reiterato H.C. Wainwright Buy
2019-01-04 Iniziato Robert W. Baird Outperform
2018-01-05 Iniziato B. Riley FBR, Inc. Buy
2017-03-16 Iniziato FBR & Co. Outperform
2017-03-02 Iniziato Instinet Buy
2016-10-07 Iniziato Guggenheim Buy
2016-03-28 Iniziato Citigroup Buy
2016-03-28 Iniziato JMP Securities Mkt Outperform
2016-03-28 Iniziato Morgan Stanley Overweight
Mostra tutto

Syndax Pharmaceuticals Inc Borsa (SNDX) Ultime notizie

pulisher
Jul 23, 2025

Syndax Pharmaceuticals Inc. Stock Analysis and ForecastDouble-digit growth - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Syndax Pharmaceuticals Inc. stockHigh-octane investment gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) CFO Keith A. Goldan Sells 1,296 Shares - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

Is Syndax Pharmaceuticals Inc. a good long term investmentFree Capital Efficiency Planning - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Acquires New Shares in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Syndax Pharmaceuticals Inc. stock priceFree Smart Trading Workshop - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) CEO Sells $69,990.86 in Stock - MarketBeat

Jul 21, 2025
pulisher
Jul 20, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Sold by Teacher Retirement System of Texas - Defense World

Jul 20, 2025
pulisher
Jul 19, 2025

Analysts Set Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) PT at $34.10 - MarketBeat

Jul 19, 2025
pulisher
Jul 19, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Cut to $35.00 by Analysts at UBS Group - MarketBeat

Jul 19, 2025
pulisher
Jul 18, 2025

Top Executives at Syndax Pharmaceuticals Make Significant Stock Moves! - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Syndax Pharmaceuticals Executives Sell Shares for Tax Obligations - TradingView

Jul 18, 2025
pulisher
Jul 18, 2025

Is Syndax Pharmaceuticals Inc. stock a good hedge against inflationFree Insider Trading Tips - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

Will Syndax Pharmaceuticals Inc. stock benefit from interest rate changesBreakout Confirmation Tool - Newser

Jul 18, 2025
pulisher
Jul 18, 2025

(SNDX) Trading Advice - news.stocktradersdaily.com

Jul 18, 2025
pulisher
Jul 18, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Down 6% Following Analyst Downgrade - MarketBeat

Jul 18, 2025
pulisher
Jul 17, 2025

UBS Group Has Lowered Expectations for Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

Syndax Pharmaceuticals (NASDAQ:SNDX) Trading Down 6% on Analyst Downgrade - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Syndax CFO and CEO sell shares at $9.29/share on July 16, 2025. - AInvest

Jul 16, 2025
pulisher
Jul 16, 2025

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Consensus Rating of “Moderate Buy” by Analysts - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Syndax’s Revuforj Granted FDA Priority Review for Relapsed/Refractory Mutant NPM1 AML - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

Why Syndax Pharmaceuticals Inc. stock attracts strong analyst attentionSmart Growth Low Risk Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Syndax Pharmaceuticals Inc. stock price move sharplyPro Trader Stock Focus - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

UBS Lowers Price Target for Syndax Pharmaceuticals (SNDX) to $35 - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

How Syndax Pharmaceuticals Inc. stock performs during market volatilityFree Day Trading Recommendations - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

UBS Adjusts Price Target on Syndax Pharmaceuticals Inc to $35 From $37, Maintains Buy Rating - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

UBS Adjusts Price Target for Syndax (SNDX) While Maintaining Pos - GuruFocus

Jul 15, 2025
pulisher
Jul 13, 2025

The Goldman Sachs Group Begins Coverage on Syndax Pharmaceuticals (NASDAQ:SNDX) - MarketBeat

Jul 13, 2025

Syndax Pharmaceuticals Inc Azioni (SNDX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Capitalizzazione:     |  Volume (24 ore):